|
Bayer delivers on medical innovation fueling transformation of pharma business
|
21 February 2022 |
|
Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing
|
25 January 2022 |
|
Bayer and Mammoth Biosciences to collaborate on novel gene editing technolog
|
10 January 2022 |
|
Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
|
10 August 2021 |
|
Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson's disease
|
08 June 2021 |
|
Bayer to manufacture mRNA vaccine in Germany
|
01 February 2021 |
|
Bayer transforms pharma business through breakthrough innovation in healthcare
|
14 January 2021 |
|
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
|
07 January 2021 |
|
Bayer and Informed Data Systems Inc. (One Drop) join forces to jointly develop digital health products across therapeutic areas
|
24 August 2020 |
|
Bayer supports "The Challenge Initiative" of Johns Hopkins Bloomberg School of Public Health with 10 million USD
|
19 June 2020 |
|
Bayer to support Harvard Research Study to evaluate trust in science, including in COVID-19 pandemic
|
01 June 2020 |
|
Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments
|
21 April 2020 |
|
Bayer and Nuvisan create new research unit in Berlin
|
11 February 2020 |
|
Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery
|
09 January 2020 |
|
New set-up for IT at Bayer
|
12 December 2019 |
|
Bayer selects Pharmaron as partner organization
|
28 November 2019 |
|
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
|
14 November 2019 |
|
Bayer invests USD 50 Million in eGenesis Series B financing round
|
11 November 2019 |
|
Bayer launches LifeHub UK focused on artificial intelligence to optimize data-driven drug discovery and disease diagnosis
|
22 October 2019 |
|
Bayer inks deals with eleven startups under G4A Digital Health Partnerships program
|
10 October 2019 |